Design, synthesis, in vitro evaluation of tetrahydropyrimidine-isatin hybrids as potential antibacterial, antifungal and anti-tubercular agents

Chinese Chemical Letters

Volumn 23, Issue 4, 2012, Pages 446-449

  Akhaja, Tarunkumar Nanjibhai ^a   Raval, Jignesh Priyakant ^a  

^a Ashok & Rita Patel Institute of Integrated Study and Research in Biotechnology and Allied Sciences   (India)

Author keywords

1,3 Dihydro 2H indol 2 ones; Antibacterial and antifungal activity; Biginelli reaction; CaCl 2 catalyst; In vitro antituberculer activity; Isatin; Tetrahydropyrimidines

Indexed keywords

EID: 84859005110     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cclet.2012.01.040     Document Type: Article

References (23)

1. C. Biot, and K. Chibale Infect. Disord. Drug Targets 6 2006 173
2. S.M. Sondhi, S. Jain, and M. Dinodia Bioorg. Med. Chem. 15 2007 3334
3. M.H. Jung, J. Park, and K.J. Yang Arch. Pharm. Pharm. Med. Chem. 334 2001 79
4. G.V. De Lucca, J. Liang, and I. De Lucca J. Med. Chem. 42 1999 135
5. E.A. Muravyova, S.M. Desenko, and V.I. Musatov J. Comb. Chem. 9 2007 797
6. A.C. Nair, P. Jayatilleke, and X. Wang J. Med. Chem. 45 2002 973
7. M.S. Pani, M. Arjun, and D. Sridhar Chin. Chem. Lett. 20 2009 909
8. A.D. Shutalev, A.A. Fesenko, and D.A. Cheshkov Tetrahedron Lett. 49 2008 4099
9. R.H. Hans, I.J.F. Wiid, and P.D. Van Helden Bioorg. Med. Chem. Lett. 21 2011 2055 and references cited there of Ref. [9]
10. T.C. Wang, J.Z. Wei, and C.S. Guo Chin. Chem. Lett. 21 2010 1407
11. Y.L.N. Murthy, N. Karthikeyan, and G. Boddeti Chin. Chem. Lett. 22 2011 567
12. I. Chiyanzu, C. Clarkson, and P.J. Smith Bioorg. Med. Chem. 13 2005 3249
13. R.A. Lyer, and P.E. Hanna Bioorg. Med. Chem. Lett. 5 1995 89
14. R.S. Lamani, N.S. Shetty, and R.R. Kamble Eur. J. Med. Chem. 44 2009 2828
15. X.J. Song, Y. Shao, and X.G. Dong Chin. Chem. Lett. 22 9 2011 1036
16. B. Testa, P. Crivori, M. Reist, and P.A. Carrupt Perspect. Drug Discov. Des. 19 2000 179
17. K. Miura, T. Nakagawa, and A. Hosomi J. Am. Chem. Soc. 124 4 2002 536
18. K. Miura, K. Tamaki, T. Nakagawa, and A. Hosomi Angew. Chem. Int. Ed. 39 2000 1958
19. K.K. Pasunooti, H. Chai, and C.N. Jensen Tetrahedron Lett. 52 2011 80
20. T.N. Akhaja, and J.P. Raval Eur. J. Med. Chem. 46 2011 5573
21. 4. Products obtained as dark yellowish precipitate. Crystallization was carried out using THF:Water (80:20). Yield: 3a, 70-72% & 3b, 72-74%, mp: 3a, 189-190°C & 3b, 180-181°C
22. H.D. Isenberg Clinical Microbiology Procedures Handbook vol. 1 1992 American Society for Microbiology Washington, DC
23. A. Rattan Antimicrobials in Laboratory Medicine 2000 Churchill B.I. Livingstone, New Delhi p. 85